MDB Insider Sale Notice: 1,174 Shares via Morgan Stanley on NASDAQ

Rhea-AI Filing Summary

MongoDB (MDB) has a Form 144 notice showing a proposed sale of 1,174 common shares through Morgan Stanley Smith Barney on the NASDAQ with an aggregate market value of $384,989.82. The shares were acquired and are to be sold on 09/17/2025 following a stock option exercise paid in cash. The filing lists 81,356,893 shares outstanding for the issuer. The filer represents they are not aware of any undisclosed material adverse information and the form includes the standard attestation language regarding Rule 10b5-1 if applicable.

Positive

• Transparent disclosure of broker, trade date, acquisition method, and aggregate market value
• Securities derived from a stock option exercise with cash payment, indicating routine insider liquidity
• Attestation that the filer is not aware of undisclosed material adverse information

Negative

• Insider sale of common shares, which some investors monitor for sentiment (1,174 shares, $384,989.82)
• Form does not indicate whether a Rule 10b5-1 trading plan applies (field left blank), creating limited context

Insights

Financial Analyst

TL;DR: Routine insider sale following option exercise; size small relative to outstanding shares, so likely immaterial to valuation.

The filing documents a sale of 1,174 shares valued at roughly $385k, resulting from an option exercise and immediate sale through Morgan Stanley. For a company with 81.36 million shares outstanding, this transaction is immaterial in market-cap terms and appears to be personal liquidity rather than a corporate action. The disclosure is timely and conforms to Rule 144 reporting norms.

Compliance/Risk Analyst

TL;DR: Form 144 provides required transparency; includes the standard attestation about material nonpublic information.

The notice specifies acquisition and sale dates matching 09/17/2025, the nature of acquisition as a stock option exercise, and cash payment. It names the broker and exchange, satisfying procedural elements. The attestation reduces regulatory ambiguity; no indication in this filing of Rule 10b5-1 reliance or undisclosed risks.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1174	384989.82	81356893	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/17/2025	Stock Option Exercise	ISSUER			1174	09/17/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MongoDB's (MDB) Form 144 disclose?

The filing discloses a proposed sale of 1,174 common shares via Morgan Stanley on 09/17/2025 with an aggregate market value of $384,989.82.

How were the shares acquired for the sale listed in the Form 144?

The shares were acquired on 09/17/2025 by stock option exercise from the issuer and paid in cash.

On which exchange will the MongoDB shares be sold according to the filing?

The filing states the shares are to be sold on the NASDAQ through Morgan Stanley Smith Barney LLC.

How many MongoDB shares are outstanding per this Form 144?

The filing reports 81,356,893 shares outstanding for the issuer.

Does the Form 144 indicate the filer knows of any undisclosed material information?

The filer represents by signature that they do not know any material adverse information that has not been publicly disclosed.

Does the Form 144 show prior sales by the filer in the past three months?

The filing indicates "Nothing to Report" for securities sold during the past three months.